Business Context and Reporting Period
This Form 8-K is a current report filed by Nephros, Inc. on April 23, 2025. The filing discloses a corporate governance event regarding the Board of Directors scheduled for the 2025 Annual Meeting of Stockholders on June 16, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change disclosed is the departure of a director:
- Alisa Lask has notified the Board that she will not stand for re-election at the upcoming annual meeting.
- Her term on the Board will expire at the conclusion of the 2025 Annual Meeting.
- The Company explicitly states that this decision was not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business strategy. No new risks, contingencies, or unusual items were disclosed in this specific report.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following the June 16, 2025, Annual Meeting to confirm if a replacement for Alisa Lask is nominated.
- Confirm that the departure of Ms. Lask remains unrelated to any undisclosed operational or governance disputes.
- Review subsequent filings for any impact on board committee assignments or corporate governance policies.